Loading...
Ibrexafungerp: A Novel Oral Triterpenoid Antifungal in Development for the Treatment of Candida auris Infections
Candida auris is an emerging multidrug-resistant fungal pathogen reported worldwide. Infections due to C. auris are usually nosocomial and associated with high rates of fluconazole resistance and mortality. Echinocandins are utilized as the first-line treatment. However, echinocandins are only avail...
Na minha lista:
| Udgivet i: | Antibiotics (Basel) |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7559578/ https://ncbi.nlm.nih.gov/pubmed/32854252 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antibiotics9090539 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|